首页> 外文期刊>Environmental toxicology and chemistry >THE VALUE OF REPEATING STUDIES AND MULTIPLE CONTROLS: REPLICATED 28-DAY GROWTH STUDIES OF RAINBOW TROUT EXPOSED TO CLOFIBRIC ACID
【24h】

THE VALUE OF REPEATING STUDIES AND MULTIPLE CONTROLS: REPLICATED 28-DAY GROWTH STUDIES OF RAINBOW TROUT EXPOSED TO CLOFIBRIC ACID

机译:重复研究和多重控制的价值:取代虹膜虹膜虹鳟的28天生长研究

获取原文
获取原文并翻译 | 示例
       

摘要

Two studies to examine the effect of waterborne clofibric acid (CA) on growth-rate and condition of rainbow trout were conducted using accepted regulatory tests (Organisation for Economic Co-operation and Development [OECD] 215). The first study (in 2005) showed significant reductions after 21 d of exposure (21 -d growth lowest-observed-effect concentration [LOEC] = 0.1 μg/L, 21 -d condition LOEC = 0.1 μg/L) that continued to 28 d. Growth rate was reduced by approximately 50% (from 5.27 to 2.67% per day), while the condition of the fish reduced in a concentration-dependant manner. Additionally, in a concentration-dependent manner, significant changes in relative liver size were observed, such that increasing concentrations of CA resulted in smaller livers after 28-d exposure. A no-observed-effect concentration (NOEC) was not achieved in the 2005 study. An expanded second study (in 2006) that included a robust bridge to the 2005 study, with four replicate tanks of eight individual fish per concentration, did not repeat the 2005 findings. In the 2006 study, no significant effect on growth rate, condition, or liver biometry was observed after 21 or 28 d (28-d growth NOEC = 10 μg/ L, 28-d condition NOEC = 10 μg/L), contrary to the 2005 findings. We do not dismiss either of these findings and suggest both are relevant and stand for comparison. However, the larger 2006 study carries more statistical power and multiple-tank replication, so probably produced the more robust findings. Despite sufficient statistical power in each study, interpretation of these and similar studies should be conducted with caution, because much significance is placed on the role of limited numbers of individual and tank replicates and the influence of control animals.
机译:使用公认的监管测试(经济合作与发展组织[OECD] 215)进行了两项研究,以研究水基氯纤维酸(CA)对虹鳟鱼生长速率和状况的影响。第一项研究(2005年)显示暴露后21 d显着降低(21 d生长最低观测效应浓度[LOEC] = 0.1μg/ L,21 d条件LOEC = 0.1μg/ L)持续至28 d。生长速度降低了约50%(从每天5.27降低到2.67%),而鱼的状况则以浓度依赖的方式降低。另外,以浓度依赖性的方式,观察到相对肝脏大小的显着变化,使得暴露于28天后CA浓度增加导致肝脏变小。在2005年的研究中未达到无观察到的浓度(NOEC)。扩展的第二项研究(2006年)包括通往2005年研究的坚固桥梁,其中每个浓度有八个鱼的四个重复鱼缸,没有重复2005年的发现。在2006年的研究中,在21或28天后(28天生长的NOEC = 10μg/ L,28天条件下的NOEC = 10μg/ L),未观察到对生长速率,状况或肝脏生物学的显着影响。 2005年的发现。我们不会忽略这些发现中的任何一个,并建议两者都是相关的,并有待比较。但是,2006年规模较大的研究具有更大的统计能力和多罐复制功能,因此可能得出了更为可靠的发现。尽管每项研究都有足够的统计能力,但对这些研究和类似研究的解释仍应谨慎,因为在有限数量的个体和坦克复制品的作用以及对照动物的影响方面,意义重大。

著录项

  • 来源
    《Environmental toxicology and chemistry》 |2010年第12期|p.2831-2839|共9页
  • 作者单位

    Institute for the Environment, Brunei University, Uxbridge, Middlesex UB8 3PH, United Kingdom;

    Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut 06340, USA;

    AstraZeneca, Safety Health and Environment, Brixham Environmental Laboratory, Brixham, Devon, United Kingdom;

    AstraZeneca, Safety Health and Environment, Brixham Environmental Laboratory, Brixham, Devon, United Kingdom;

    AstraZeneca, Safety Health and Environment, Brixham Environmental Laboratory, Brixham, Devon, United Kingdom;

    AstraZeneca Pharmaceuticals US, Wilmington, Delaware, USA;

    Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut 06340, USA;

    Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut 06340, USA;

    Institute for the Environment, Brunei University, Uxbridge, Middlesex UB8 3PH, United Kingdom;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    clofibric acid; rainbow trout; pharmaceuticals; growth; environmental risk assessment;

    机译:纤维酸虹鳟鱼;药品;增长环境风险评估;
  • 入库时间 2022-08-17 13:32:19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号